NASDAQ: EXAS
Exact Sciences Corp Earnings Dates, Reports, Calls

Exact Sciences earnings were -$986.6M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest EXAS earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$19.6M, up 1,553.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, EXAS reported annual earnings of -$1.0B, with 404% growth.

EXAS earnings history

Current Revenue
$3.1B
Current Earnings
-$986.6M
Current Profit Margin
-32%

EXAS Return on Equity

Current Company
-40.4%
Current Industry
-2%
Current Market
36.1%
EXAS's Return on Equity (-40.4%)... subscribe to Premium to read more.
High Return on Equity Performance

EXAS undefined

Current Company
-16.9%
Current Industry
6.8%
EXAS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when EXAS announces earnings.

EXAS undefined

Current Company
-17.98%
Current Industry
14.5%
EXAS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

EXAS vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
EXAS-$710.69M-$986.58MN/A-$5.35
ILMN$1.27B$703.00M+0.59%$4.47
DGX$2.10B$969.00M+1.05%$8.64
MEDP$563.19M$433.01M+33.48%$14.66
LH$2.21B$855.20M+3.40%$10.25

Exact Sciences Earnings Reports & History FAQ

What were Exact Sciences's earnings last quarter?

On EXAS's earnings call on Invalid Date, Exact Sciences (NASDAQ: EXAS) reported Q3 2025 earnings per share (EPS) of -$0.10, up 52.38% year over year. Total EXAS earnings for the quarter were -$19.59 million. In the same quarter last year, Exact Sciences's earnings per share (EPS) was -$0.21.

If you're new to stock investing, here's how to buy Exact Sciences stock.

Is Exact Sciences profitable or losing money?

As of the last Exact Sciences earnings report, Exact Sciences is currently losing money. Exact Sciences's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$986.58 million, a 360.94% increase year over year.

What was EXAS's earnings growth in the past year?

As of Exact Sciences's earnings date in Invalid Date, Exact Sciences's earnings has grown year over year. EXAS earnings in the past year totalled -$986.58 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.